[go: up one dir, main page]

ATE46081T1 - Arzneimittelzusammensetzungen und deren verwendung als mydriatische mittel. - Google Patents

Arzneimittelzusammensetzungen und deren verwendung als mydriatische mittel.

Info

Publication number
ATE46081T1
ATE46081T1 AT86900669T AT86900669T ATE46081T1 AT E46081 T1 ATE46081 T1 AT E46081T1 AT 86900669 T AT86900669 T AT 86900669T AT 86900669 T AT86900669 T AT 86900669T AT E46081 T1 ATE46081 T1 AT E46081T1
Authority
AT
Austria
Prior art keywords
pct
medicinal compositions
mydriatic agent
sec
date
Prior art date
Application number
AT86900669T
Other languages
English (en)
Inventor
Angelo Carenzi
Cesare Casagrande
Oreste Cerri
Giovanna Miragoli
Franco Pozzi
Michele Virno
Original Assignee
Simes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes filed Critical Simes
Application granted granted Critical
Publication of ATE46081T1 publication Critical patent/ATE46081T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT86900669T 1984-12-27 1985-12-24 Arzneimittelzusammensetzungen und deren verwendung als mydriatische mittel. ATE46081T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT24266/84A IT1178800B (it) 1984-12-27 1984-12-27 Composizioni farmaceutiche e loro uso come midriatici
EP86900669A EP0205606B1 (de) 1984-12-27 1985-12-24 Arzneimittelzusammensetzungen und deren verwendung als mydriatische mittel
PCT/EP1985/000744 WO1986003970A1 (en) 1984-12-27 1985-12-24 Pharmaceutical compositions and their use as mydriatics

Publications (1)

Publication Number Publication Date
ATE46081T1 true ATE46081T1 (de) 1989-09-15

Family

ID=11212828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86900669T ATE46081T1 (de) 1984-12-27 1985-12-24 Arzneimittelzusammensetzungen und deren verwendung als mydriatische mittel.

Country Status (7)

Country Link
US (1) US4764530A (de)
EP (1) EP0205606B1 (de)
JP (1) JPH078788B2 (de)
AT (1) ATE46081T1 (de)
DE (1) DE3572768D1 (de)
IT (1) IT1178800B (de)
WO (1) WO1986003970A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231488B (it) * 1988-11-09 1991-12-07 Zambon Spa Soluzione acquosa farmaceutica tamponata a ph 4,5 per uso oftalmico contenente ibopamina e idrossipropilmetilcellulosa
IT1247508B (it) * 1991-04-19 1994-12-17 Zambon Spa Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
EP1435930A2 (de) * 2001-10-15 2004-07-14 National Research Council Of Canada Glykierungsinhibitoren zur prävention von komplikationen des alters, der diabetes und des rauchens
ITMI20040146A1 (it) * 2004-01-30 2004-04-30 Acraf Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono
US20240065999A1 (en) * 2020-11-09 2024-02-29 The Board Of Trustees Of The Leland Stanford Junior University Ophthalmic Formulation Containing a Dopaminergic Prodrug that may be Combined with One or More Agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5140499U (de) * 1974-09-11 1976-03-25
US3959485A (en) * 1975-04-10 1976-05-25 Interx Research Corporation Method of reducing intraocular pressure in warm-blooded animals
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
JPS554423U (de) * 1978-06-22 1980-01-12
US4275074A (en) * 1979-03-09 1981-06-23 Graham J. Dobbie Catecholamine treatment of ocular hypertension
EP0067910B1 (de) * 1981-06-18 1986-02-26 Maurice E. Langham Verbindungen und Zusammensetzungen für die Behandlung von okularem Hochdruck
US4479967A (en) * 1982-09-30 1984-10-30 Ciba-Geigy Corporation Method of lowering intraocular pressure with ibuterol
IT1194325B (it) * 1983-07-19 1988-09-14 Simes Composizioni farmaceutiche comprendenti epinina o un suo sale farmaceuticamente accettabile e loro uso terapeutico

Also Published As

Publication number Publication date
DE3572768D1 (en) 1989-10-12
IT8424266A0 (it) 1984-12-27
EP0205606B1 (de) 1989-09-06
JPH078788B2 (ja) 1995-02-01
US4764530A (en) 1988-08-16
WO1986003970A1 (en) 1986-07-17
JPS63502270A (ja) 1988-09-01
IT1178800B (it) 1987-09-16
EP0205606A1 (de) 1986-12-30

Similar Documents

Publication Publication Date Title
ATE152630T1 (de) Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
NO971192D0 (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
DE69309712D1 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
ES2090857T3 (es) Composiciones para el cuidado del cabello.
FR2647343B1 (fr) Nouvelle forme pharmaceutique poreuse et sa preparation
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
IT1131750B (it) Formulazioni stabili di n-(3,4-diclorofenil)-n'metossi-n'-metilurea (linorun) e 2,6-dinitor-n,n-dipropil-4-trifluoro metilanilina (trifluralin) in emulsione
ATE199167T1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
ATE243196T1 (de) Piperidine und pyrrolidine
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
SE9401540D0 (sv) Munhygienkomposition
ATE46081T1 (de) Arzneimittelzusammensetzungen und deren verwendung als mydriatische mittel.
SE9402880D0 (sv) New peptide derivatives
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
IL95046A0 (en) Substituted 2-imidazolines and pharmaceutical compositions containing them
ATE198481T1 (de) Bizyclische tachykinin-antagonisten, deren herstellung und deren verwendung in pharmazeutischen zusammmensetzungen
ATE130628T1 (de) Antioxydantsystem auf basis einer basischen aminosäure und eines tocopherols.
TR200100801T2 (tr) Benzoilguanidin türevleri, imalatlarına yönelik yöntemler, ilaç yapımında kullanımı
DE69323191D1 (de) Wasserlösliche retinoide
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time